Earum Pharmaceuticals Ltd. - Research Center
542724 EARUM-RE Group (R) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Sep ' 19 | |
|---|---|---|---|---|---|
| Sales | 11.39 | 9.63 | 11.41 | 38.85 | 27.95 |
| Operating profit | -0.42 | -4.29 | -0.13 | -4.08 | 0.67 |
| Interest | - | - | 0.08 | 0.46 | 0.48 |
| Gross profit | 0.45 | 1.13 | 2.07 | -1.46 | 1.21 |
| EPS (Rs) | 0.06 | 0.04 | 0.32 | -0.49 | 0.28 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Sep ' 19 | |
|---|---|---|---|---|---|
| Other income | 0.87 | 5.42 | 2.28 | 3.08 | 1.02 |
| Stock adjustment | 0.92 | -1.05 | 4.26 | 5.25 | -1.58 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | - | 0.02 | 0.02 | 0.16 | 0.14 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 10.88 | 14.94 | 7.26 | 37.52 | 28.72 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.05 | 0.04 | 0.08 | 0.06 | 0.05 |
| Taxation | - | 0.86 | - | - | 0.30 |
| Net profit / loss | 0.40 | 0.24 | 1.99 | -1.52 | 0.85 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.34 | 12.34 | 12.34 | 6.17 | 6.17 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -3.67 | -44.55 | -1.17 | -10.50 | 2.39 |
| GPM (%) | 3.66 | 7.52 | 15.10 | -3.48 | 4.18 |
| NPM (%) | 3.26 | 1.58 | 14.51 | -3.62 | 2.95 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis